NCT04934930View on ClinicalTrials.gov

Adjustment of Chemotherapy Duration in Follicular Lymphoma According to Minimal Residual Disease Status

PHASE2UnknownINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 29, 2020

Primary Completion Date

August 1, 2025

Study Completion Date

August 1, 2025

Conditions
Follicular Lymphoma
Interventions
DRUG

Bendamustin

Chemotherapy

DRUG

Obinutuzumab

Immunotherapy

Trial Locations (1)

Unknown

RECRUITING

Meir medical center, Kfar Saba

Sponsors
All Listed Sponsors
collaborator

Rabin Medical Center

OTHER

collaborator

Tel-Aviv Sourasky Medical Center

OTHER_GOV

collaborator

Assuta Ashdod Hospital

OTHER

collaborator

Ziv Medical Center

OTHER

lead

Meir Medical Center

OTHER